13F-HR: General Electric's Q2 2024 13F Filing Reveals Major Healthcare Tech Holdings

General Electric's latest 13F filing discloses significant holdings in GE Healthcare Technologies and Hyliion Holdings Corp as of June 30, 2024.

Summary

• General Electric CO filed its Form 13F for the quarter ended June 30, 2024.
• The filing reports holdings for two issuers: GE Healthcare Technologies and Hyliion Holdings Corp.
• GE Healthcare Technologies holdings are valued at $2,378,999,052, representing 30,531,302 shares.
• Hyliion Holdings Corp holdings are valued at $8,910,000, representing 5,500,000 shares.
• The total value of all holdings reported in the filing is $2,387,909,052.

Sentiment

Score: 6

Explanation: The document is a standard 13F filing, which is neutral in tone. The large holding in GE Healthcare suggests a positive outlook on that company, but the filing itself doesn't express explicit sentiment.

Positives

• The filing indicates a substantial investment in GE Healthcare Technologies, reflecting confidence in the company's prospects.

Industry Context

13F filings provide insights into the investment strategies of large institutional investors like General Electric, offering a glimpse into their portfolio allocations and sentiment towards specific companies and sectors, such as healthcare technology and electric vehicle components.

Comparison to Industry Standards

• Comparing GE's holdings to other institutional investors' 13F filings in the same period could reveal broader trends in investment sentiment towards GE Healthcare Technologies and Hyliion Holdings Corp.
• Analyzing the concentration of GE's portfolio in these two companies relative to industry benchmarks can indicate their conviction in these specific investments.
• Benchmarking the performance of GE's holdings against relevant market indices (e.g., healthcare technology indices, electric vehicle indices) can provide insights into the effectiveness of their investment strategy.

Stakeholder Impact

• Shareholders of GE Healthcare Technologies and Hyliion Holdings Corp may react to the disclosure of GE's holdings, potentially influencing their stock prices.
• The filing provides transparency to the market regarding GE's investment positions.

Key Dates